Colgate-Palmolive
Stock Snapshot
Price Performance
Vista Outlook
View Technicals Analysis →Basis of our Recommendation
Colgate-Palmolive (India) Limited is navigating a pivotal phase characterized by a strategic focus on premiumization and operational efficiency, which management believes will drive long-term growth. Recent earnings reports indicate a return to revenue growth, with a notable 9.2% increase in domestic sales and a strong emphasis on expanding its premium oral care portfolio. This shift is supported by a significant rise in advertising expenditure, aimed at bolstering brand strength amidst competitive pressures. While EBITDA margins are temporarily compressed due to these investments, the company's high gross margins provide a buffer for continued brand-building initiatives. Vista's financial outlook reflects a cautious optimism, projecting a 9% revenue CAGR and an 11% EBITDA CAGR through FY28, underpinned by the successful execution of premiumization strategies. However, the company faces headwinds from competitive intensity and rising commodity costs, which could impact margins. Overall, Colgate-Palmolive's commitment to innovation and market share defense positions it well for future growth, although the balance between investment and margin stability will be critical in the coming 12-24 months
Why We Like This Stock
- Strong recovery in revenue growth, with a 9.2% increase in domestic sales driven by premiumization
- High gross margins provide a buffer for continued investment in brand-building and innovation
- Management's focus on operational efficiency and digital transformation supports long-term growth potential
Things To Watch Out For
- Temporary compression of EBITDA margins due to increased advertising expenditures
- Intensifying competition from local and D2C brands poses risks to market share
- Rising commodity costs and inflationary pressures could further impact margins
Key Parameters
Financial Snapshot
| Actuals | Forecast | ||||
|---|---|---|---|---|---|
| FY24 | FY25 | FY26 | FY27 | FY28 | |
| Revenue (Cr.) | 5,680 | 6,040 | 6,035 | 6,392 | 6,886 |
| Profit Before Tax (Cr.) | 1,801 | 1,930 | 1,809 | 1,805 | 2,041 |
| PBT Margin | 31.7% | 32.0% | 2997.5% | 28.2% | 29.6% |
| Net Profit (Cr.) | 1,302 | 1,434 | 1,327 | 1,320 | 1,492 |
| Earnings Per Share | 47.9 | 52.7 | 48.8 | 48.5 | 54.9 |
Analyst Recommendations
| Broker | Recommendation | Target Price | Date |
|---|---|---|---|
| Citigroup | ▼ Sell | 2,000 | 30-Jul-2026 |
| Emkay Global | ▼ Reduce | 2,050 | 30-Jul-2026 |
| Goldman Sachs | ▼ Sell | 2,050 | 30-Jul-2026 |
| HDFC Securities | ▼ Reduce | 2,000 | 30-Jul-2026 |
| HSBC | ► Hold | 2,140 | 30-Jul-2026 |
| ICICI Securities | ► Hold | 2,250 | 30-Jul-2026 |
| JPMorgan | ► Hold | 2,250 | 10-Jun-2026 |
| Jeffries | ▲ Buy | 2,650 | 30-Jul-2026 |
| Kotak Securities | ▼ Sell | 2,025 | 25-May-2026 |
| Moneycontrol | ► Equalweight | nan | 30-Jul-2026 |
| Motilal Oswal | ▲ Buy | 2,500 | 30-Jul-2026 |
| Nomura | ▲ Buy | 2,550 | 30-Jul-2026 |
| Prabhudas Liladhar | ► Hold | 2,214 | 25-May-2026 |
Company Overview
Show Company Profile
Colgate-Palmolive (India) Limited manufactures and trades in personal and oral care products in India. The company offers toothpastes, toothpowder, toothbrushes, mouth wash, serum, rinses, whitening products, hand washes, and shower gels under the Colgate and Palmolive brand name. It also offers soaps, cosmetics, and toiletries. In addition, the company exports its products. Colgate-Palmolive (India) Limited was incorporated in 1937 and is headquartered in Mumbai, India.